Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT02374372

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02374372
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02374372. Randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing the Hemodiafiltration On-line and Conventional Hemodialysis in Terms of Cost-benefit
Acronym
PHARMACO-$
Condition
Chronic Renal Failure
Condition
Hemodialysis
Intervention (Device)
conventional hemodialysis
Intervention (Device)
hemodiafiltration On-line
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (class: other)

Record details

Record id
cardio:ct-nct02374372
Content hash
dd93f0da17231fb14e4897c8fefcaca0610a159550defc078627c6528f41dbbe